Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

MedAustron becomes first center in the world to use RayCommand to treat patients

RaySearch is proud to annouce that the treatment control system RayCommand®* is in clinical use at the innovative center MedAustron in Wiener Neustadt in Austria. Through this milestone MedAustron also becomes the first oncology center where RayStation®*, RayCare®* and RayCommand are used together to treat patients.MedAustron is a pioneering center for ion therapy and research, specialized in advanced cancer treatment using protons and carbon ions, which is the most advanced form of radiation therapy. The center is one of only six comparable centers worldwide.  RaySearch and MedAustron

BEWI becomes 100% owner of leading UK based insulation and packaging company Jablite Group

BEWI, a leading provider of packaging, components, and insulation solutions, announces that the company acquires an additional 51 per cent of the leading UK based insulation and packaging company Jablite Group (“Jablite”), with an annual turnover of approximately GBP 40 million, becoming 100 per cent owner of the company. BEWI first announced its acquisition of 49 per cent of Jablite in June 2020. Jablite has approximately 50 years of experience from innovating and developing EPS solutions for insulation and packaging. The Jablite Group includes the manufacturer and supplier of solutions

SkartaNYAB Plc - Managers' Transactions

SkartaNYAB PlcMANAGERS' TRANSACTIONS18 May 2022 at 14:30SkartaNYAB Plc - Managers' Transactions____________________________________________Person subject to the notification requirementName: BINGAB Barents Investment Group ABPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In IssuerName: Johan LarssonPosition: Chief Executive Officer Issuer: SkartaNYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 15234/4/4____________________________________________ Transaction

Correction: Q1 Report – 31 March 2022

Correction refers to earnings per share where basic earnings per share should read GBP 0.51 pence and diluted earnings per share should read GBP 0.48 pence.Flexion produces another quarter with record results: revenue growth rises by 61% and adjusted EBITDA by 419%.January-March 2022 performance · Total revenue increased by 61% to GBP 10.6m (6.6)* · Gross profit increased by 78% to GBP 1.5m (0.8) · Adjusted EBITDA[‡] increased by 419% to GBP 0.49m (-0.15) · Operating result increased to GBP 0.25m (-0.14) · Earnings per share amounted to GBP 0.51 pence (-0.48 pence) ·

Attana now offers self sampling for expanded diagnostic testing capabilities with an updated CE IVD-marking

Attana now enables self sampling through an updated CE IVD-marking for capillary blood samples using Capitainer[®]qDBS cards (quantitative dried blood spot), enabling laboratories improved opportunities to perform immune profiling and monitoring of vaccine efficacy in broad patient populations.As presented together with Capitainer in February 2022, the goal of Attana Diagnostics is to offer broader and more patient-centric blood sampling solutions for the Attana AVA[TM] system. Since then, Attana has validated its AVA[TM] SARS-CoV-2 IgG Immunoassay kit for capillary blood samples, both qDBS

Gasum considers that natural gas imports from Russia could end this week

Gasum considers there to be a real risk of the natural gas supplies under the company’s gas supply contract ending and that it is likely that imports of natural gas from Russia to Finland will cease either late on Friday, May 20 or on Saturday, May 21, 2022. Gasum has not received any information about the matter from Gazprom Export or from the Russian transmission operator.Gasum will continue preparing for the situation together with its customers and the national authorities responsible for emergency supply. During the coming summer season, Gasum will aim to ensure the availability of gas

Kamux Corporation: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Kamux Corporation, Stock Exchange Release / Flagging Release, 18.5.2022 at 14:15 Kamux Corporation: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act Kamux Corporation has received on May 17, 2022 the following notification pursuant to Chapter 9, Section 5 of the Securities Markets Act (“SMA”), according to which the total holding of funds (Swedbank Robur Nordenfond ja Swedbank Robur Småbolagsfond Norden) managed by Swedbank Robur Fonder AB (Sundbyberg, Sweden) in Kamux Corporation shares and votes has decreased below five (5) percent on May

The Kemi bioproduct mill reached roof height

Metsä Fibre press release 18.5.2022The topping out ceremony for the Kemi bioproduct mill of Metsä Fibre, part of Metsä Group, was held today, Wednesday, 18 May 2022. Topping out is a traditional ceremony at construction sites, organised when the roofs have been completed, and the buildings have reached their maximum height. Keynote speeches at the event were given by CEO Ismo Nousiainen, Project Director Jari-Pekka Johansson, Construction Manager Eelon Lappalainen and On-Site Contact Person Mika Vuoti. The Pohjan mieslaulajat choir also performed at the ceremony. Because of coronavirus

Wihlborgs conducts share split

The Annual General Meeting of Wihlborgs Fastigheter AB (publ) held on 26 April 2022, resolved on a two-for-one division of the company’s shares (a “split”), by which each old share will be replaced with two new shares. The Board was authorised to establish a record date for the split.The Board has decided that the record date for the split is 24 May 2022 and the new shares are expected to be registered in shareholders’ accounts on 25 May 2022. The last day of trading in shares before the split is 20 May 2022 and the first day of trading in shares after the split is 23 May 2022. The new

SLP builds energy-efficient logistics property in Malmö

SLP will build a modern and energy-efficient logistics building of approximately 2,000 sqm on its property Grimskaftet 1 in southern Malmö. Café Bar will be the first tenant and will rent 550 sqm for a period of seven years from the completion of the new premises. Building permit application will be submitted in the second quarter of 2022.In line with SLP’s sustainability goals, the new building will be certified according to Miljöbyggnad silver.   “We are happy that we have found a location that will be adapted to our business and that we can do it together with SLP. Like SLP, we are

Tradedoubler AB: Report from Tradedoubler’s Annual General Meeting

The Annual General Meeting of TradeDoubler AB (publ) was held on 18 May 2022. Dividend The Annual General Meeting resolved that no dividend should be paid to the shareholders. Board of Directors and auditor The Annual General Meeting discharged the board and the CEO from liability for the financial year 2021. Pascal Chevalier, Gautier Normand, Jérémy Parola and Erik Siekmann were re-elected as Board members. Pascal Chevalier was re-elected as chairman of the Board of Directors. EY was re-elected as auditor for one year. Remuneration to the Board of Directors and

Newsletter  -  Recent Presentations of Hamlet Pharma

Hamlet Pharma has participated in a number of recent events, presenting highligts from the promising clinical studies and our future strategy. With this newsletter, we would like to invite you to see these presentations, using the links below.Hamlet Pharma's drug candidate Alpha1H has shown great promise as a cancer treatment in animal models and in clinical studies. We have chosen bladder cancer as the first clinical indication. Bladder cancers are extremely common and difficult to treat. The a lack of new therapies makes bladder cancer one of the most expensive cancer forms and the FDA

press release May 18 2022 Synact Pharma to present at the ABGSC Life Science Summit

Stockholm, Sweden — Synact Pharma AB (”SynAct” eller ”Bolaget”) today announces that the company will present at the ABGSC Life Science Summit on May 19, 2022. The company will be represented by Chairman Dr. Torbjørn BjerkeThe presentation will be available after the meeting on Synact Pharmas website; www.synactpharma.com. The information was submitted, through the agency of the contact persons below, for publication on May 18, 2022.

BEWI – Invitation to presentation of results for the first quarter of 2022

BEWI, a leading provider of packaging, components, and insulation solutions, will announce its results for the first quarter of 2022 on Friday 20 May 2022. The results will be available from 07:00 am CEST at the company's homepage, www.bewi.com and Oslo Børs' news site, www.newsweb.no CEO Christian Bekken and CFO Marie Danielsson will present the results from 08:30 at the premises of Pareto Securities at the 11th floor of in Dronning Mauds gate 3 in Oslo, Norway. The presentation is open to all. The presentation will also be available through a live webcast. The link to the webcast

CEO Review 2021: Growth despite challenges

We had an eventful and yet again challenging year in 2021. We have managed to grow our net sales by more than 9%, creating 419 million euros worth of net sales and keeping our EBITDA at a good level of 26 million. This was done, although we faced many global challenges such as raw material shortages, price increases and continuing pandemic. We accomplished this through continuous dialogue and flexibility in collaboration with our partners and with the hard work of the Teknos Family. During the year we continued to work with our main strategic initiatives: sustainability, innovation,

“We knew we had to do something – we didn’t want to wait” - IKEA Poland’s work finding jobs for their displaced Ukrainian neighbours

What can businesses do to help the growing number of people experiencing forced displacement from their homes around the world? This is a question Ingka Group has been asking itself for many years, with global initiatives such as Skills for Employment  finding ways to reach out and offer training and employment to people who need it most. Now, with ever increasing number of people forcibly displaced globally, Ingka Group is extending its effort to connect, communicate, recruit, and

Read original

Gedea Biotech to Start EpHect Clinical Trial for Antibiotic-free Treatment of Women with Vulvo Vaginal Candidiasis

Lund, Sweden, May 18, 2022. Gedea Biotech today announces that it has received regulatory approval from the Ethics Committee and the Swedish Medical Products Agency and will start the EpHect clinical study of its lead product, pHyph, a vaginal tablet for topical treatment. The open-labelled study is designed to confirm the safety and efficacy of pHyph in treating adult women with confirmed Vulvo Vaginal Candidiasis (VVC) and in restoring a beneficial vaginal microbiome to prevent recurrence of the infection. The study will be conducted at four Swedish clinics and at a clinic in United Kingdom.

Tele2 delivers 5G private network to X Shore’s factory in Nyköping, Sweden

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) Tele2 has signed an agreement with electric boat company X Shore to build a private 5G network in their newly built factory in Nyköping, Sweden. By having its own 5G network, X Shore will become more flexible and efficient in its production of the electric boats of the future.Digitalization across industries is increasing and with this also comes the need for stable connectivity. In Nyköping, Sweden, X Shore is establishing a new facility with the ambition of becoming the world's most sustainable boat factory, with the

Q1 Interim Report 1 January – 31 March 2022

Risk Intelligence A/S (“Risk Intelligence” or "Company") hereby publishes the Q1 Interim Report for the period January - March 2022. The report is available on the Company's investor website (investor.riskintelligence.eu).Highlights · Strong continued growth in recurring revenue by 20% · Net Retention Rate 105% · Revenue decreased by 7% · EBITDA Q1 decreased by 141% · Net profit Q1 decreased by 98% · Full year guidance for 2022 intact Reporting period Q1: January 2022 – March 2022 DKK ‘000 3,924 (4,240) -7% · Revenue:

Annual General Meeting of New Wave Group AB (publ)

New Wave Group AB held its Annual General Meeting (AGM) on 18 May 2022. Due to the spread of the coronavirus, the AGM was carried out through postal voting without physical attendance, pursuant to temporary legislation.-          The EGM resolved, in accordance with the Board of Directors’ proposal, on a dividend of SEK 4.25 per share with 20 May 2022 as record date for entitlement to receive dividend. -            Each Board Member and the CEO were discharged from liability for the fiscal year 2021. -            The AGM resolved on the following fees payable to the Board and the

DSRT: Desert Control Q1 2022 Report and Interim Financial Results | Webcast presentation 25 May 10:00 CET

ISSUER DESERT CONTROL AS Desert Control Q1 2022 Report and Interim Financial Results will be released onWednesday 25 May 2022 at 0730 AM Central European Time (Oslo).The Q1 Report and presentation will be made available athttps://www.desertcontrol.com/investorsA webcast presentation in English will be hosted on Wednesday 25 May at 10.00 AMCentral European Time.Registration:https://desertcontrol.zoom.us/webinar/register/WN_7ed9wg_qTE2JQ8CRbeR8eQAfter the presentation, there will be a Q&A session. Questions can be submittedin advance to erling.rasmussen@desertcontrol.

Strategic partnership agreement between HC Andersen Capital and Inderes Oyj has now been formalised

On 8 April 2022, HC Andersen Capital announced a strategic partnership agreement with the listed Finish company, Inderes Oyj. The partnership agreement has now been formalised, and Inderes Oyj has become a minority shareholder in HC Andersen Capital.The strategic partnership relates to Inderes’ technology platform and a common ambition to create a Nordic investor relations platform.It is the mission of Inderes to democratize investor information – very similar to HC Andersen Capital. Inderes has created an advanced digital platform providing efficient investor communication, including an

There are no items matching the current filter
There are no more items matching the current filter
Back to top